Synopsys (SNPS) discloses 2,693 restricted stock units for executive chair

Rhea-AI Filing Summary

Synopsys Inc reported an equity award to its Executive Chair and director, Aart de Geus. On 12/16/2025, he received 2,693 restricted stock units classified as derivative securities with an exercise price of $0.0, beneficially owned directly.

The grant was approved by the Compensation Committee under the Synopsys, Inc. 2006 Employee Equity Incentive Plan. One-sixth of the units vest on 06/15/2026, followed by five equal semi-annual installments, conditioned on continued service through each vesting date. The RSUs are scheduled to expire on 12/15/2028.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DE GEUS AART

(Last) (First) (Middle)

675 ALMANOR AVENUE

(Street)

SUNNYVALE CA 94085

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SYNOPSYS INC [ SNPS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EXECUTIVE CHAIR

3. Date of Earliest Transaction (Month/Day/Year)
12/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0.0	12/16/2025		A(1)		2,693		06/15/2026(2)	12/15/2028	Common Stock	2,693	$0.0	2,693	D

Explanation of Responses:

1. The Compensation Committee of the Board of Directors approved a restricted stock unit grant under the Synopsys, Inc. 2006 Employee Equity Incentive Plan.

2. One-sixth (1/6) of the units vest on the date shown followed by five equal semi-annual installments, subject to continued service through each vesting date.

	By: POA pursuant Mary Lai For: Aart de Geus	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Synopsys (SNPS) disclose for Aart de Geus?

Synopsys disclosed that Executive Chair and director Aart de Geus received a grant of 2,693 restricted stock units on 12/16/2025, reported as derivative securities beneficially owned directly.

How many restricted stock units were granted in the latest Synopsys (SNPS) Form 4?

The report shows a grant of 2,693 restricted stock units to Aart de Geus, recorded as derivative securities with an exercise price of $0.0.

What is the vesting schedule for Aart de Geus’s new Synopsys restricted stock units?

According to the disclosure, one-sixth (1/6) of the units vest on 06/15/2026, with the remaining units vesting in five equal semi-annual installments, subject to continued service through each vesting date.

Under which equity plan were the new Synopsys (SNPS) restricted stock units granted?

The restricted stock unit grant was approved by the Compensation Committee under the Synopsys, Inc. 2006 Employee Equity Incentive Plan.

What is the expiration date of the reported Synopsys restricted stock units?

The reported restricted stock units for Aart de Geus are shown with an expiration date of 12/15/2028.

How are the newly granted Synopsys derivative securities held by Aart de Geus?

The filing lists 2,693 derivative securities (restricted stock units) as beneficially owned following the transaction, with an ownership form indicated as Direct (D).